Gyrodyne , LLC (NASDAQ:GYRO – Get Free Report) was the target of a large growth in short interest in February. As of February 27th, there was short interest totaling 72 shares, a growth of 38.5% from the February 12th total of 52 shares. Approximately 0.0% of the company’s stock are short sold. Based on an average daily volume of 179 shares, the short-interest ratio is presently 0.4 days. Based on an average daily volume of 179 shares, the short-interest ratio is presently 0.4 days. Approximately 0.0% of the company’s stock are short sold.
Institutional Investors Weigh In On Gyrodyne
Hedge funds have recently made changes to their positions in the business. Susquehanna International Group LLP bought a new position in Gyrodyne during the third quarter valued at about $142,000. Advisory Services Network LLC bought a new stake in Gyrodyne in the third quarter worth about $77,000. Bulldog Investors LLP purchased a new position in Gyrodyne in the third quarter valued at about $601,000. Finally, Teton Advisors LLC purchased a new position in Gyrodyne in the third quarter valued at about $177,000. 71.36% of the stock is currently owned by institutional investors.
Gyrodyne Price Performance
Shares of NASDAQ GYRO traded down $0.85 during midday trading on Friday, reaching $7.90. The company’s stock had a trading volume of 1,322 shares, compared to its average volume of 492. The firm has a 50 day moving average price of $8.88 and a 200-day moving average price of $9.49. Gyrodyne has a 12-month low of $6.80 and a 12-month high of $12.00.
Gyrodyne Company Profile
Gyrodyne Company of America, Inc is a New York–based real estate investment and development firm specializing in medical office buildings and professional facilities. Listed on the NASDAQ under the ticker GYRO, the company’s principal business activity is the ownership, leasing and management of commercial properties tailored to healthcare and life sciences tenants. By focusing on outpatient diagnostic and treatment centers, clinical laboratories and related professional suites, Gyrodyne generates steady rental income and seeks to provide purpose-built environments that meet the specific needs of medical practitioners and research organizations.
The company’s core property portfolio is anchored by an approximately 87-acre campus situated in Stony Brook, Long Island.
Read More
- Five stocks we like better than Gyrodyne
- 840% Gains… and his next pick?
- Elon Musk’s $1 Quadrillion AI IPO
- Do this before SpaceX IPOs or be sorry
- How JPMorgan’s $8,000 Gold Call Will Leave Most Retirement Accounts Behind
- Silver paying 20% dividend. Plus 68% share gains
Receive News & Ratings for Gyrodyne Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Gyrodyne and related companies with MarketBeat.com's FREE daily email newsletter.
